The potential clinical utility of amplicon and targeted nanopore sequencing for rare disease

Nanopore sequencing as a potential diagnostic tool for genetic diseases in the Middle EastПодробнее

Potential use of nanopore sequencing in clinical cancer genomicsПодробнее

Nanopore sequencing reveals retrotransposon insertions or complex genetic mechanisms rare disordersПодробнее

Uncovering rare disease-causing variantsПодробнее

Amplicons to whole genomes: clinical sequencing using nanopore technology | Andrew BeggsПодробнее

Long-read sequencing for pathogenic and novel variation discovery in rare diseasesПодробнее

Maximizing the power of genomic sequencing in pediatric rare diseaseПодробнее

Levin Joe Klages: Analysis of clinical research samples by nanopore sequencingПодробнее

Efficient targeted sequencing using nanopore sequencingПодробнее

Solving genetically undiagnosed inherited neuropathy families: long-read sequencing to the rescueПодробнее

Improved detection and clinical interpretation of rare disease variantsПодробнее

Team Pitches – UnifAIПодробнее

PromethION - flexible, scalable, on-demand sequencingПодробнее

Genomic Sequencing Advancements Provide Answers to Rare Diseases | Summer's StoryПодробнее

Ryan McGinty | Lightning TalkПодробнее

Katherine Dixon - Characterising structural variants in rare diseaseПодробнее

The potential use of nanopore sequencing for molecular diagnosis of germline cancer predispositionПодробнее

Ron Ammar | Nanopore Sequencing for Detection of Pharmacogenomic Variants and HaplotypesПодробнее